Concurrent with the filing of our Proxy Statement dated April 17, 2017, we are disclosing that Ann F. Putallaz, Ph.D., will not stand for re-election to our Board of Directors due to age-related requirements as set forth in our By-Laws.

Our Chairman and Chief Executive Officer, W. Stancil Starnes, said, “Ms. Putallaz has been a key member of the Board during her tenure, which dates back to the inception of ProAssurance, as Medical Assurance, Inc. and Professionals Group merged. The expertise she brought to the Audit Committee, in particular, was vital to our compliance with emerging financial regulations during the financial crisis. We are indebted to her for her immensely valuable and dedicated service.”

The ProAssurance Board of Directors has nominated Katisha T. Vance, M.D., to replace Ms. Putallaz on our Board. Dr. Vance is a board-certified oncologist / hematologist practicing at Birmingham Hematology and Oncology (d/b/a Alabama Oncology) in Birmingham, Alabama. She is also the President of the Jefferson County Medical Society. Dr. Vance received her M.D. degree from University of Alabama School of Medicine in Birmingham, Alabama, trained in internal medicine at Baptist Health System in Birmingham, Alabama, and completed a fellowship in medical oncology and hematology at the University of Alabama at Birmingham.

Mr. Starnes said, “Dr. Vance will bring new insights and a fresh viewpoint to our Board. Her position as a leader of organized medicine will provide deeper insights into the evolving environment in which many of our customers practice.”

Additionally, we are highlighting the fact that our Chairman and Chief Executive Officer, W. Stancil Starnes is not standing for re-election to the Board of Directors of Infinity Property and Casualty Corporation (“Infinity”), as disclosed in a Current Report on Form 8K filed by Infinity on February 28, 2017. This will bring Mr. Starnes into compliance with “overboarding” guidelines set forth by certain proxy advisory agencies.

About ProAssurance Corporation (NYSE:PRA)

ProAssurance Corporation is a holding company for property and casualty insurance companies. The Company provides professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, liability insurance for medical technology and life sciences risks, and workers’ compensation insurance. It operates in four segments: Specialty property and casualty, which includes its professional liability business, and medical technology and life sciences business; Workers’ compensation, which includes its workers’ compensation business, which it provides for employers, groups and associations; Lloyd’s syndicate, which includes operating results from its participation in Lloyd’s Syndicate 1729, and Corporate. In addition, the Company is also a provider for Lloyd’s of London Syndicate 1729, which writes a range of property and casualty insurance, and reinsurance lines.

ProAssurance Corporation (NYSE:PRA) Recent Trading Information

ProAssurance Corporation (NYSE:PRA) closed its last trading session up +1.05 at 60.10 with 173,340 shares trading hands.